Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Molecules (Basel, Switzerland)|October 14, 2022
Cheminformatics Modeling of Gene Silencing for Both Natural and Chemically Modified siRNAsXialan Dong, Weifan Zheng
Future Medicinal Chemistry|June 29, 2011
Structure-based quantitative structure--activity relationship modeling of estrogen receptor β-ligandsXialan Dong, Solomon G Hilliard, Weifan Zheng
Current Chemical Genomics|February 18, 2010
Development of improved models for phosphodiesterase-4 inhibitors with a multi-conformational structure-based QSAR methodAdetokunbo Adekoya, Xialan Dong, Jerry Ebalunode, et al.
Journal of Chemical Information and Modeling|January 26, 2010
A novel structure-based multimode QSAR method affords predictive models for phosphodiesterase inhibitorsXialan Dong, Jerry O Ebalunode, Sung Jin Cho, et al.
Current Computer-Aided Drug Design|July 6, 2011
Receptor-based pharmacophore and pharmacophore key descriptors for virtual screening and QSAR modelingXialan Dong, Jerry O Ebalunode, Sheng-Yong Yang, et al.
Bioorganic & Medicinal Chemistry|June 13, 2009
Structure-based shape pharmacophore modeling for the discovery of novel anesthetic compoundsJerry O Ebalunode, Xialan Dong, Zheng Ouyang, et al.
Molecules (Basel, Switzerland)|September 3, 2020
Literature-Wide Association Studies (LWAS) for a Rare Disease: Drug Repurposing for Inflammatory Breast CancerXiaojia Ji, Chunming Jin, Xialan Dong, et al.
Journal of Biomedical Informatics|October 2, 2020
A semantic similarity based methodology for predicting protein-protein interactions: Evaluation with P53-interacting kinasesSteven Cox, Xialan Dong, Ruhi Rai, et al.
Journal of Biomedical Informatics|June 13, 2021
Learning Drug-Disease-Target Embedding (DDTE) from knowledge graphs to inform drug repurposing hypothesesChangsung Moon, Chunming Jin, Xialan Dong, et al.
Pageof 4